Reported 2 days ago
Novavax, Inc. (NASDAQ:NVAX) is highlighted as one of the 'unstoppable stocks' with the potential to double investors' money. The biotechnology company has made significant strides in vaccine development and is anticipating profitable operations by 2027. Despite recent market volatility, analysts remain optimistic about Novavax's growth, particularly with its innovative vaccine technology and strategic partnerships. The stock has shown a 50% return over the last year, securing its position as a leading choice for potential high returns in the evolving market landscape.
Source: YAHOO